GENE ONLINE|News &
Opinion
Blog

Tyrosine Kinase
COVID-19 JAK1 Inhibitor
Novartis Announces Failure of Ruxolitinib Trial in Severe COVID-19
2020-12-18
R&D Breast Cancer
Seattle Genetics Enters Breast Cancer Market with Tukysa
2020-04-21
Trials & Approvals Breast Cancer
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
R&D Acute Myeloid Leukemia
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
LATEST
From Vision to Victory: Foxconn’s AI Factory Blueprint and Multi-Million Dollar Investments
2025-05-22
NVIDIA’s Global AI Strategy: A Multi-Region Push with Taiwan and Middle East as Key Hubs
2025-05-22
MIRDC Establishes CDMO Innovation Center in Boston to Advance into Innovative Healthcare
2025-05-22
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
NIH Restores Research Funding to Previously Defunded Scientists Amid Policy Shifts
2025-05-20
Prime Medicine Reduces Workforce by 25 Percent and Appoints David Schenkein as New CEO
2025-05-20
READ MORE
EVENT
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top